Cargando…
Unlocking the potential of Tregs: innovations in CAR technology
Regulatory T cells (Tregs) adoptive immunotherapy is emerging as a viable treatment option for both autoimmune and alloimmune diseases. However, numerous challenges remain, including limitations related to cell number, availability of target-specific cells, stability, purity, homing ability, and saf...
Autores principales: | Requejo Cier, Christopher J., Valentini, Nicolas, Lamarche, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602912/ https://www.ncbi.nlm.nih.gov/pubmed/37900916 http://dx.doi.org/10.3389/fmolb.2023.1267762 |
Ejemplares similares
-
Do small RNAs unlock the below ground microbiome-plant interaction mystery?
por: Regmi, Roshan, et al.
Publicado: (2022) -
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
por: Du, Li, et al.
Publicado: (2021) -
Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis
por: Zhang, Pengpeng, et al.
Publicado: (2023) -
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
por: Mika, Thomas, et al.
Publicado: (2020) -
Mapping CAR T-Cell Design Space Using Agent-Based Models
por: Prybutok, Alexis N., et al.
Publicado: (2022)